Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice (2020)
- Authors:
- Autor USP: GIANNELLA, MARIA LUCIA CARDILLO CORREA - FM
- Unidade: FM
- DOI: 10.2147/DMSO.S242282
- Subjects: DIABETES MELLITUS; GLICOSÍDEOS; RATOS; FÍGADO GORDUROSO
- Agências de fomento:
- FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/09463-8, 2017/19449-9]
- Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES)CAPES [001]
- Sao Paulo State Foundation for Research (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/15603-0]
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Diabetes metabolic syndrome and obesity-targets and therapy
- ISSN: 1178-7007
- Volume/Número/Paginação/Ano: v. 13, p. 739-751, 2020
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc
-
ABNT
DAVID-SILVA, Aline et al. Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice. Diabetes metabolic syndrome and obesity-targets and therapy, v. 13, p. 739-751, 2020Tradução . . Disponível em: https://doi.org/10.2147/DMSO.S242282. Acesso em: 23 maio 2024. -
APA
David-Silva, A., Esteves, J. V., Morais, M. R. P. T., Freitas, H. S., Zorn, T. M., Giannella, M. L. C. C., & Machado, U. F. (2020). Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice. Diabetes metabolic syndrome and obesity-targets and therapy, 13, 739-751. doi:10.2147/DMSO.S242282 -
NLM
David-Silva A, Esteves JV, Morais MRPT, Freitas HS, Zorn TM, Giannella MLCC, Machado UF. Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice [Internet]. Diabetes metabolic syndrome and obesity-targets and therapy. 2020 ; 13 739-751.[citado 2024 maio 23 ] Available from: https://doi.org/10.2147/DMSO.S242282 -
Vancouver
David-Silva A, Esteves JV, Morais MRPT, Freitas HS, Zorn TM, Giannella MLCC, Machado UF. Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice [Internet]. Diabetes metabolic syndrome and obesity-targets and therapy. 2020 ; 13 739-751.[citado 2024 maio 23 ] Available from: https://doi.org/10.2147/DMSO.S242282 - Efeito dos produtos finais de glicacao avancada (AGES) sobre a expressao dos genes do fator de crescimento insulina simile do tipo 1 (IgF-1) e de sua proteina de ligacao do tipo 4 (IgFBP-4) em celulas musculares lisas isoladas de aorta humana em cultura
- Association between tumoral GH-releasing peptide receptor type 1a mRNA expression and in vivo response to GH-releasing peptide-6 in ACTH-dependent Cushing's syndrome patients
- Pioglitazone modulates the lipid metabolism, cell cycle, and cell death gene expression profile in pancreatic islets
- Evalution of the expression of incretin receptors in rat pancreatic islets explosed to human amylin and to lipotoxicity
- Visceral adiposity syndrome
- Glutathione peroxidase-1 gene (GPX1) variants, oxidative stress and risk of kidney complications in people with type 1 diabetes
- Bases moleculares da oncogênese hipofisária
- MicroRNAs 1915-3p, 2861, and 4532 Are Associated with Long-Term Renal Function Decline in Type 1 Diabetes [Carta]
- Reproducibility of a nylon fishing line as a screening test for diabetic foot ulceration risk [Editorial]
- Diabete melito tipo 1 - tratamento
Informações sobre o DOI: 10.2147/DMSO.S242282 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
